-
公开(公告)号:US20210177736A1
公开(公告)日:2021-06-17
申请号:US17186229
申请日:2021-02-26
Applicant: FUJIFILM Corporation
Inventor: Haruki TOMIKAWA , Koji TAKAKU , Kosuke CHIBA , Takafumi HOSOKAWA
Abstract: Provided is a biocompatible material capable of forming a gel having excellent retention and scratch resistance. The biocompatible material according to the embodiment of the present invention includes an alginate having a weight-average molecular weight of 1 million or more, an aluminum compound, a carboxyvinyl polymer, and an oil-based base material. However, the biocompatible material is substantially free of water.
-
公开(公告)号:US20230265058A1
公开(公告)日:2023-08-24
申请号:US18166235
申请日:2023-02-08
Applicant: FUJIFILM Corporation
Inventor: Takafumi NAKAYAMA , Kosuke CHIBA , Naoyuki MOROOKA
IPC: C07D241/42 , C07C57/50 , C07C59/72 , G02B1/04
CPC classification number: C07D241/42 , C07C57/50 , C07C59/72 , G02B1/041 , C07C2603/10
Abstract: Provided are a compound represented by the following General Formula (A1-1), a method for producing the same, and the use of the compound:
wherein R5 and R6 represent a hydrogen atom or an alkyl group, L1 and L2 represent an alkylene group having 1 to 6 carbon atoms, Spa and Spb represent a single bond or a divalent linking group, R11 and R21 represent a substituent, and v1 and w1 are an integer of 0 to 4. Further provided that a structure represented by (R11)v1-benzen ring/cyclopentadiene skeleton/naphthalene ring-(R21)w1 is not line-symmetrical, where “/” represents that two rings described on left and right sides of the structure are fused.-
公开(公告)号:US20210196826A1
公开(公告)日:2021-07-01
申请号:US17198417
申请日:2021-03-11
Applicant: FUJIFILM Corporation
Inventor: Kosuke CHIBA , Koji TAKAKU
Abstract: The present invention provides a biomaterial that is excellent in scratch resistance and retention in a case of being brought into contact with water. The biomaterial according to the embodiment of the present invention is a biomaterial including a neutral acyl lipid, at least one selected from the group consisting of a phospholipid and a quaternary ammonium salt, and a carboxyvinyl polymer. The neutral acyl lipid includes at least one selected from the group consisting of a neutral monoacyl lipid and a neutral diacyl lipid, and a content of the at least one selected from the group consisting of the neutral monoacyl lipid and the neutral diacyl lipid is 80% by mass to 100% by mass with respect to a total mass of the neutral acyl lipid.
-
4.
公开(公告)号:US20230212136A1
公开(公告)日:2023-07-06
申请号:US18091139
申请日:2022-12-29
Applicant: FUJIFILM Corporation
Inventor: Kosuke CHIBA , Naozumi SHIRAIWA , Takafumi NAKAYAMA , Naoyuki MOROOKA
IPC: C07D339/06 , C01G19/02 , G02B27/42 , G02B1/04
CPC classification number: C07D339/06 , C01G19/02 , G02B1/041 , G02B27/4211 , C01P2004/64
Abstract: Provided are a curable resin composition including a near-ultraviolet light-absorbing organic compound, indium tin oxide particles, and a polymer having a constitutional unit represented by General Formula (P) and having an acidic group at one terminal, in which the near-ultraviolet light-absorbing organic compound is a compound that has a maximal value at 300 to 400 nm in an absorption spectrum in a wavelength region of 300 to 800 nm and does not substantially absorb light at a wavelength of 410 to 800 nm; a cured product formed of the curable resin composition; a diffractive optical element; and a multilayer diffractive optical element.
ArP represents an aryl group and LP and RP1 represent a specific group.-
公开(公告)号:US20210379098A1
公开(公告)日:2021-12-09
申请号:US17407132
申请日:2021-08-19
Applicant: FUJIFILM Corporation
Inventor: Kosuke CHIBA , Koji TAKAKU , Haruki TOMIKAWA
IPC: A61K31/765 , A61K31/14 , A61K31/231 , A61K31/685
Abstract: A biomaterial includes a neutral acyl lipid and an amphipathic block copolymer which contains a hydrophilic segment and a hydrophobic segment and in which a difference in ClogP value between the hydrophilic segment and the hydrophobic segment is more than 1.00, and in the biomaterial, a content of the amphipathic block copolymer is 1.0% to 20% by mass with respect to a total mass of a solid content of the biomaterial.
-
-
-
-